BIOTECHNOLOGY INNOVATION ORGANIZATION: Form 990, tax year 2012

View the entire original 990 at ProPublica ↗

Organization
BIOTECHNOLOGY INNOVATION ORGANIZATION (EIN 52-1224577)
Tax period
2012-01-01 to 2012-12-31
Filed
2013-11-14
IRS object ID
201313189349301501
Schema version
2012v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2013-11-14T09:58:59-06:00Timestamp
Tax Period End Date2012-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN410746749EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line14250 N FAIRFAX DRIVE SUITE 1020AddressLine1
CityARLINGTONCity
StateVAState
ZIP Code22203ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2012-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN521224577EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1BIOTECHNOLOGY INDUSTRY ORGANIZATIONBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlBIOTNameControl
Phone2029629200Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameJOANNE M DUNCANName
TitleCFO & SVP, FINANCE & ADMINTitle
Phone2029629200Phone
Date Signed2013-11-11DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameKAREN GRIESName
PTINP00078514PTIN
Phone5712279500Phone
FieldValueIRS element (for citing)
Tax Year2012TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonJAMES C GREENWOODNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVENUE SW NO 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode
FieldValueIRS element (for citing)
Gross Receipts96516207GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501cXOrganization501c
Web SiteWWW.BIO.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1993YearFormation
State Legal DomicileDCStateLegalDomicile
Activity Or Mission DescriptionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) MISSION IS TO SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEALTH CARE, ENHANCED AGRICULTURE AND A CLEANER AND SAFER ENVIRONMENT. IT IS BIO'S MISSION TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE OF OUR MEMBER ORGANIZATIONS BOTH LARGE AND SMALL.ActivityOrMissionDescription
Nbr Voting Members Governing Body116NbrVotingMembersGoverningBody
Nbr Independent Voting Members116NbrIndependentVotingMembers
Total Nbr Employees184TotalNbrEmployees
Total Nbr Volunteers196TotalNbrVolunteers
Total Gross UBI338892TotalGrossUBI
Net Unrelated Business Txbl Income-11938NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year0ContributionsGrantsPriorYear
Contributions Grants Current Year0ContributionsGrantsCurrentYear
Program Service Revenue Prior Year59284196ProgramServiceRevenuePriorYear
Program Service Revenue CY59883011ProgramServiceRevenueCY
Investment Income Prior Year1994532InvestmentIncomePriorYear
Investment Income Current Year2400453InvestmentIncomeCurrentYear
Other Revenue Prior Year3900OtherRevenuePriorYear
Other Revenue Current Year3959OtherRevenueCurrentYear
Total Revenue Prior Year61282628TotalRevenuePriorYear
Total Revenue Current Year62287423TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year0GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY232395GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year25311029SalariesEtcPriorYear
Salaries Etc Current Year27075315SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year0TotalFundrsngExpCurrentYear
Other Expense Prior Year35650393OtherExpensePriorYear
Other Expenses Current Year37619628OtherExpensesCurrentYear
Total Expenses Prior Year60961422TotalExpensesPriorYear
Total Expenses Current Year64927338TotalExpensesCurrentYear
Revenues Less Expenses Prior Year321206RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-2639915RevenuesLessExpensesCY
Total Assets BOY65857637TotalAssetsBOY
Total Assets EOY65054922TotalAssetsEOY
Total Liabilities BOY27777267TotalLiabilitiesBOY
Total Liabilities EOY26151093TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY38080370NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY38903829NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionTHE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS MORE THAN 1,100 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
DescriptionADVOCACYBIO'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2012 ARE LISTED BELOW. SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY. FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY. PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH. INITIATED EFFORTS TO COMPREHENSIVELY REFORM THE U.S. TAX CODE TO PROMOTE INNOVATION AND INVESTMENT IN BIOTECHNOLOGY. EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2012 ACCOMPLISHMENTS: INFLUENCED IMPROVEMENTS TO THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW. ENHANCED PATIENT ACCESS TO INNOVATIVE THERAPIES. ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION. PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES. ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS. INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE EMERGING COMPANIES SECTION 2012 ADVOCACY ACCOMPLISHMENTS: ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY. INCREASED OPPORTUNITIES FOR SMALL COMPANIES TO RECEIVE FEDERAL GRANTS. ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES. ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES. INFLUENCED BIO'S HEALTH CARE POLICIES TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION 2012 ADVOCACY ACCOMPLISHMENTS: WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS IN AN EFFORT TO PROVIDE PREDICTABILITY IN REGULATORY DECISIONS. COMPLETED WORK ON THE FIRST AGREEMENT UNDER A VOLUNTARY INDUSTRY MECHANISM ("THE ACCORD") DESIGNED TO PROVIDE A TRANSITION PROCESS FOR PRODUCTS COMING OFF PATENT AND ENTERING THE GENERIC MARKETPLACE. FOSTERED SUPPORT OF NONTRADITIONAL ALLIES THROUGH ONGOING OUTREACH TO ENVIRONMENTAL, ANTI-HUNGER AND CORPORATE ENTITIES, AS WELL AS INTERNATIONAL OFFICIALS, TO ADVANCE UNDERSTANDING OF AGRICULTURE BIOTECHNOLOGY AND THE CHALLENGES RELATED TO UNPREDICTABLE REGULATORY SYSTEMS. SECURED A LETTER TO THE EU COMMISSION RAISING OBJECTIONS TO ITS ANIMAL CLONING REGULATORY POLICIES FROM THE UNITED STATES AND A GROUP OF LIKE-MINDED COUNTRIES. DEFEATED LEGISLATION DESIGNED TO SCARE AND MISINFORM CONSUMERS REGARDING FOOD DERIVED FROM BIOTECHNOLOGY INGREDIENTS.THE INDUSTRIAL & ENVIRONMENTAL SECTION 2012 ADVOCACY ACCOMPLISHMENTS: SUCCESSFULLY ADVOCATED FOR CONGRESS TO PRESERVE THE RENEWABLE FUELS STANDARD. SUCCESSFULLY ADVOCATED FOR THE INTRODUCTION OF SEVERAL FAVORABLE PIECES OF TAX LEGISLATION RELATING TO RENEWABLE CHEMICALS, ALGAE, CELLULOSIC AND OTHER ADVANCED BIOFUELS. WORKED TO SECURE A ROBUST ENERGY TITLE IN FARM BILL REAUTHORIZATION PROPOSALS IN CONGRESS. ADVOCATED REGARDING THE PROPER REGULATORY APPROACH IN THE EMERGING FIELD OF SYNTHETIC BIOLOGY. ADVOCATED FOR THE CERTIFICATION PROCESS FOR THE VOLUNTARY LABELING PROGRAM IN THE U.S. DEPARTMENT OF AGRICULTURES BIOPREFERRED PROGRAM. BIO HELD TWO INDUSTRIAL BIOTECH CONFERENCES IN 2012 THE BIO WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY AND BIOPROCESSING AND THE BIO PACIFIC RIM SUMMIT ON INDUSTRIAL BIOTECHNOLOGY AND BIOENERGY.Description

Activity2 Activity2

FieldValueIRS element (for citing)
DescriptionSERVICESBIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE EVENT ATTRACTED 16,500 ATTENDEES FROM 65 COUNTRIES, AND 49 U.S. STATES, INCLUDING 300 MEMBERS OF THE MEDIA. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION AND THE BIO BUSINESS FORUM, WHICH TAKES PLACE DURING THE CONVENTION, PROVIDED AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO SCHEDULE ONE-ON-ONE MEETINGS AND DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. THE BIO BUSINESS FORUM, WHICH TAKES PLACE DURING THE CONVENTION, PROVIDED AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO SCHEDULE ONE-ON-ONE MEETINGS AND DISCUSS POTENTIAL BUSINESS OPPORTUNITIES; IT HOSTED A RECORD NUMBER OF 25,537 PARTNERING MEETINGS BETWEEN 2,837 COMPANIES AND 150+ COMPANY PRESENTATIONS.CAPITAL FORMATION & BUSINESS DEVELOPMENT - THROUGH A PORTFOLIO OF EVENTS, BIO SUPPORTS THE CAPITAL FORMATION AND BUSINESS DEVELOPMENT NEEDS OF HUNDREDS OF INNOVATIVE COMPANIES THAT FORM THE BASIS OF THE BIOTECHNOLOGY INDUSTRY. THESE PROGRAMS FACILITATE CRITICAL CAPITAL FORMATION AND PARTNERSHIPS, AND PROVIDE PROFESSIONAL SERVICES. THROUGHOUT THE YEAR, BIO HOSTS OR CO-HOSTS NINE NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.Description
FieldValueIRS element (for citing)
Described In501 C30DescribedIn501C3
Schedule B Required0ScheduleBRequired
Political Activities0PoliticalActivities
Subject To Proxy Tax1SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote0ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With1096180NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Number Of Employees184NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account1ForeignFinancialAccount
Name Of Foreign CountryINNameOfForeignCountry
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members116NbrVotingGoverningBodyMembers
Number Independent Voting Members116NumberIndependentVotingMembers
Family Or Business Relationship1FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders1MembersOrStockholders
Election Of Board Members1ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other0CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1JOANNE M DUNCANBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2029629200TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line11201 MARYLAND AVE SW STE 900AddressLine1
CityWASHINGTONCity
StateDCState
ZIP Code20024ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (136 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
APEL DANIEL
MEMBER2.00X000
ATWOOD BRIAN
MEMBER2.00X000
BEALL ROBERT
MEMBER2.00X000
BEEMAN DONALD
MEMBER2.00X000
BEER MARC
MEMBER2.00X000
BERVEN DOUG
MEMBER2.00X000
BIENAIME JEAN-JACQUES
MEMBER2.00X000
BORISY ALEXIS
MEMBER2.00X000
BORMANN BJ
MEMBER2.00X000
CLARK IAN
MEMBER2.00X000
COHEN RON
MEMBER2.00X000
COLES NANTHONY
MEMBER2.00X000
COLLINS JAMES
MEMBER2.00X000
CROOKES STANLEY
MEMBER2.00X000
CROWLEY JOHN
MEMBER2.00X000
CUMMINGS DANIEL
MEMBER2.00X000
DOERFLER DOUGLAS
MEMBER2.00X000
DUNCAN GREG
MEMBER2.00X000
DUNSIRE DEBORAH
MEMBER2.00X000
EGGERT CHARLES
MEMBER2.00X000
ELLERBUSCH SUSAN
MEMBER2.00X000
ENO RICHARD
MEMBER2.00X000
FERGUSON BRUCE
MEMBER2.00X000
FLINT JERRY
MEMBER2.00X000
FRITZ CAROLYN
MEMBER2.00X000
GATTO STEPHEN
MEMBER2.00X000
GERBERDING JULIE
MEMBER2.00X000
GERMANO GENO
MEMBER2.00X000
GIOVANNETTI GLEN
MEMBER2.00X000
GORMLEY GLENN
MEMBER2.00X000
GOWEN MAXINE
MEMBER2.00X000
GREENLEAF PETER
MEMBER2.00X000
GRUBER PATRICK
MEMBER2.00X000
GUTTERSON NEAL
MEMBER2.00X000
HA-NGOC TUAN
MEMBER2.00X000
HANTSON LUDWIG
MEMBER2.00X000
HASTINGS PAUL
MEMBER2.00X000
HATFIELD JEFFERY
MEMBER2.00X000
HERNDON RUSSELL
MEMBER2.00X000
HOLTZMAN STEVEN
MEMBER2.00X000
HOPPENOT HERVE
MEMBER2.00X000
HOYES JAMES
MEMBER2.00X000
JOHNSON JOHN
MEMBER2.00X000
JUNIUS DANIEL
MEMBER2.00X000
KARSEN PERRY
MEMBER2.00X000
KING RACHEL
MEMBER2.00X000
KISS ROBERT
MEMBER2.00X000
KOENIG SCOTT
MEMBER2.00X000
KOSACZ BARBARA
MEMBER2.00X000
KREMER MATTHIAS
MEMBER2.00X000
LEAHY EMER
MEMBER2.00X000
LEFF JONATHAN
MEMBER2.00X000
LEONARD JOHN
MEMBER2.00X000
LEIDEN JEFFERY
MEMBER2.00X000
LESCHLY NICK
MEMBER2.00X000
LEVINE JAMES
MEMBER2.00X000
LUNDBERG JAN
MEMBER2.00X000
MANUSO JAMES
MEMBER2.00X000
MARAGANORE JOHN
MEMBER2.00X000
MATHERS EDWARD
MEMBER2.00X000
MATHERS THOMAS
MEMBER2.00X000
MCCAULEY GORDON
MEMBER2.00X000
MCHUGH JULIE
MEMBER2.00X000
MEDFORD RUSSELL
MEMBER2.00X000
MEEKER DAVID
MEMBER2.00X000
MENLEIN JOHN
MEMBER2.00X000
MENTO STEVEN
MEMBER2.00X000
MILANO VINCENT
MEMBER2.00X000
MILLIGAN JOHN
MEMBER2.00X000
MOCH KENNETH
MEMBER2.00X000
MONROE ADAM
MEMBER2.00X000
MORRIS ARLENE
MEMBER2.00X000
NARACHI MICHAEL
MEMBER2.00X000
NICOLAIDES NICHOLAS
MEMBER2.00X000
NICOLS JOHN
MEMBER2.00X000
ORWIN JOHN
MEMBER2.00X000
OSTROVE JEFFERY
MEMBER2.00X000
PEACOCK JONATHON
MEMBER2.00X000
PELTZ STUART
MEMBER2.00X000
PERKINS ADELENE
MEMBER2.00X000
PETERSON KRISTINE
MEMBER2.00X000
POPS RICHARD
MEMBER2.00X000
PREUSS DAPHINE
MEMBER2.00X000
PRUZANSKI MARK
MEMBER2.00X000
PYOTT DAVID
MEMBER2.00X000
READNOUR ROBIN
MEMBER2.00X000
ROBIN HOWARD
MEMBER2.00X000
RODELL TIMOTHY
MEMBER2.00X000
RYDER STEVEN
MEMBER2.00X000
SACCHETTI RAYMOND
MEMBER2.00X000
SANDS ARTHUR
MEMBER2.00X000
SCHENKEIN DAVID
MEMBER2.00X000
SCHMIDT RALF-MICHAEL
MEMBER2.00X000
SHURDUT BRADLEY
MEMBER2.00X000
SIEGEL JAY
MEMBER2.00X000
SKALETSKY MARK
TREASURER2.00X000X
SLAOUI MONCEF
MEMBER2.00X000
STANDLEE CHRISTOPHER
MEMBER2.00X000
STEINER GERALD
MEMBER2.00X000
STOTISH RONALD
MEMBER2.00X000
SULLIVAN EDDIE
MEMBER2.00X000
TANDA STEPHAN
MEMBER2.00X000
TASSE DANIEL
MEMBER2.00X000
THAKRAR ATUL
MEMBER2.00X000
TUTTLE STEVEN
MEMBER2.00X000
VAN BOKKENLEN GIL
MEMBER2.00X000
VAN WART HAROLD
MEMBER2.00X000
VERBRUGGEN MARC
MEMBER2.00X000
WALBERT TIMOTHY
MEMBER2.00X000
WATKINS H THOMAS
BOARD CHAIR2.00X000X
WELLS BARBARA
MEMBER2.00X000
WOLFSON JONATHAN
MEMBER2.00X000
WONG MARK
MEMBER2.00X000
XANTHOPOULO KLEANTHIS
MEMBER2.00X000
ZAKES BRADFORD
MEMBER2.00X000
ZULLO JILL
MEMBER2.00X000
GREENWOOD JAMES
CEO & PRESIDENT40.001575000095581X
JOANNE DUNCAN
CFO & SVP, FINANCE & ADMIN40.00317125052194X
WHITAKER A SCOTT
COO40.00761738050953X
BITTENBENDER FREDERICK
VP, ALLIANCE DEVELOP. & STATE GOVERNMENT RELATIONS40.00334555052059X
DAMOND JOSEPH
SENIOR VP, INTERNATIONAL AFFAIRS40.00337255051614X
DILENGE THOMAS
GENERAL COUNSEL40.00526852051874X
ENRIGHT CATHLEEN
EVP, FOOD & AGRICULTURE SECTION40.00260469046469X
EISENBERG ALAN
EXEC VP, EMERGING COMPANIE40.00549590052894X
DEL MONTE BRENT
VP, FEDERAL GOVERNMENT REL40.00488567041659X
ERICKSON BRENT
EXEC VP, INDUSTRIAL & ENVI40.00406730049540X
FINAN AMY
VP, CORPORATE DEVELOPMENT40.00374693042325X
JOSEPH JEFFREY
VP, COMMUNICATIONS40.00298608019806X
LISAIUS KENNETH
VP, COMMUNICATIONS40.00241376043200X
LYCETT ROBERTA
VP, CONVENTIONS & CONFEREN40.00358419047080X
RADCLIFFE SARA
EXEC VP, HEALTH POLICY SEC40.00468366041814X
DENNIS SANDRA
DEPUTY GENERAL COUNSEL, HE40.00294971044000X
SAUER HANSJORG
DEPUTY GENERAL COUNSEL, IN40.00291501042024X
MCHUGH PETER
COMPLIANCE OFFICER, DEPUTY40.00266417043463X
FEISEE LILA
VP, INTERNATIONAL AFFAIRS40.00264687049474X
BASU ABHIJIT
MANAGING DIRECTOR, STATE GOVT RELATIONS40.00242409039302X
FieldValueIRS element (for citing)
Total Reportable Comp From Org8659328TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation957325TotalOtherCompensation
Number Individuals GT100 K73NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
FREEMAN COMPANIES
1600 VICEROY SUITE 100DALLASTX75247GENERAL CONTRACTOR: CONV/CONFERENCES1600074
PROJECTION INC
PO BOX 890472CHARLOTTENC28289VIDEO SERVICES: CONV/CONFERENCES759408
FIXATION MARKETING
4340 EAST-WEST HWY SUITE 200BETHESDAMD208144411MARKETING: INTN'L CONVENTION758897
LEVY RESTAURANTS FOOD SERVICE
415 SUMMER STREETBOSTONMA02210CATERING SERVICES: INTN'L CONV702429
RHODE PLANNING & MGMT SOLUTIONS
42 LADD ST SUITE 302EAST GREENWICHRI02818TRANSPORTATION SERVICES: INTN'L CONV666948
FieldValueIRS element (for citing)
Number Of Contractors GT100 K79NumberOfContractorsGT100K

Program Service Revenue ProgramServiceRevenue (4 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncomeUnrelated Business RevenueUnrelatedBusinessRevenueExclusionExclusionAmount
CONFERENCE/MEETING REVENUE5418003287514232577675297467
MEMBERSHIP DUES9000992283230722832307
BUSINESS SOLUTIONS9000994133993$4,133,993
PUBLICATION ADVERTISING5418004156914441425
FieldValueIRS element (for citing)
Total Program Service Revenue59883011TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column1579991TotalRevenueColumn
Exclusion$1,579,991ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities35049246Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities34228784Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities820462Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column820462TotalRevenueColumn
Exclusion$820,462ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionMISCELLANEOUS REVENUEDescription
Business Code900099BusinessCode
Total Revenue Column3959TotalRevenueColumn
Related Or Exempt Function Income3959RelatedOrExemptFunctionIncome
FieldValueIRS element (for citing)
Total Other Revenue3959TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column62287423TotalRevenueColumn
Related Or Exempt Function Income55414085RelatedOrExemptFunctionIncome
Unrelated Business Revenue338892UnrelatedBusinessRevenue
Exclusion$6,534,446ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total232395Total

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total8038405Total

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total15126484Total

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total1211061Total

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total1585878Total

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1113487Total

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total532270Total

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total57835Total

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total2778505Total

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

FieldValueIRS element (for citing)
Total361314Total

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total5653221Total

Advertising Advertising

FieldValueIRS element (for citing)
Total238553Total

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total1663338Total

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total738577Total

Occupancy Occupancy

FieldValueIRS element (for citing)
Total4026592Total

Travel Travel

FieldValueIRS element (for citing)
Total1226986Total

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total16970648Total

Interest Interest

FieldValueIRS element (for citing)
Total6123Total

Payments To Affiliates PaymentsToAffiliates

FieldValueIRS element (for citing)
Total1441546Total

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total1010804Total

Insurance Insurance

FieldValueIRS element (for citing)
Total100708Total

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotal
OUTREACH388057
BAD DEBT EXPENSE268187
TAXES PAID82691
EDUCATION52153

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total21520Total

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total64927338Total

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY4459681BOY
EOY2528659EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY2602547BOY
EOY3117733EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY2383665BOY
EOY2423170EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis10061437LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec6767357LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY4032862BOY
EOY3294080EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

FieldValueIRS element (for citing)
BOY52118530BOY
EOY53510015EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY260352BOY
EOY181265EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY65857637BOY
EOY65054922EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY8591779BOY
EOY9709497EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY13043071BOY
EOY10570025EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY6142417BOY
EOY5871571EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY27777267BOY
EOY26151093EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY38080370BOY
EOY38903829EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY38080370BOY
EOY38903829EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY65857637BOY
EOY65054922EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-2639915ReconcilationRevenueExpenses
Reconciliation Unrealized Invest3231009ReconciliationUnrealizedInvest
Reconcilation Other Changes232365ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited

FS Audited Basis FSAuditedBasis

FieldValueIRS element (for citing)
Financial Statement SeparateXFinancialStatementSeparate
FieldValueIRS element (for citing)
Audit Committee1AuditCommittee
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Substantially All Dues Nondeduct0SubstantiallyAllDuesNondeduct
Only In House Lobbying0OnlyInHouseLobbying
Agree To Carryover Prior Year1AgreeToCarryoverPriorYear
Dues Assessments22832307DuesAssessments
Non Ded Lobby Political Current7540000NonDedLobbyPoliticalCurrent
Non Ded Lobby Political Carryover21386NonDedLobbyPoliticalCarryover
Non Ded Lobby Political Total7561386NonDedLobbyPoliticalTotal
Aggr Amt Reported In Dues Notices7535000AggrAmtReportedInDuesNotices
Amount To Be Carried Over26386AmountToBeCarriedOver

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis5880250OtherCostOrOtherBasis
Depreciation3139071Depreciation
Book Value2741179BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis1809191OtherCostOrOtherBasis
Depreciation1628809Depreciation
Book Value180382BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis2371996OtherCostOrOtherBasis
Depreciation1999477Depreciation
Book Value372519BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings3294080TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities (2 entries)

DescriptionDescriptionAmountAmount
CAPITAL LEASE OBLIGATION$133,842
DEFERRED RENT$5,737,729
FieldValueIRS element (for citing)
Total Of Amounts5871571TotalOfAmounts
Tot Revenue Etc Audited Fincl Stmt66153660TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments3231009NetUnrealizedGainsInvestments
Other Revenues996542OtherRevenues
Revenue Not Rptd F9904227551RevenueNotRptdF990
Revenue Subtotal61926109RevenueSubtotal
Investment Expenses Not Included361314InvestmentExpensesNotIncluded
Revenue Not Rptd On Fin Stmt361314RevenueNotRptdOnFinStmt
Total Revenue Per Form99062287423TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt65330201TotExpensesEtcAuditedFinclStmt
Other Expenses Included764177OtherExpensesIncluded
Expenses Not Rptd F990764177ExpensesNotRptdF990
Expenses Subtotal64566024ExpensesSubtotal
Investment Expenses Not Included2361314InvestmentExpensesNotIncluded2
Expenses Not Rptd On Fin Stmt361314ExpensesNotRptdOnFinStmt
Total Expenses Per Form99064927338TotalExpensesPerForm990

Form990 Schedule D Part XIII Form990ScheduleDPartXIII (2 entries)

IdentifierIdentifierExplanationExplanation
PART XI, LINE 2D - OTHER ADJUSTMENTS:CBI 41,340. CBI LOBBYING FUND 433,424. FOOD & AG INITIATIVES REVENUE 209,301. FOOD & AG LEGAL FUND 22,762. SUSTAINABLE TASK FORCE 9,715. MEDICARE EXPENSES 280,000.
PART XII, LINE 2D - OTHER ADJUSTMENTS:FOOD & AG INITIATIVES EXPENSES 14,827. CBI LOBBYING FUND 469,350. MEDICARE EXPENSES 280,000.

Schedule F IRS990ScheduleF

Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EUROPE01PROGRAM SERVICESCONFERENCE147971
SOUTH ASIA03PROGRAM SERVICESCONFERENCE225217
EAST ASIA AND THE PACIFIC02PROGRAM SERVICESCONFERENCE1633470
NORTH AMERICA00PROGRAM SERVICESCONFERENCE213144
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees6SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees6TotalNumberOfEmployees
Subtotal Amount Spent2219802SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent2219802TotalAmountSpent
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained0RecordsMaintained

Recipient Table RecipientTable (18 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantIRC SectionIRCSection
ALLIANCE FOR A STRONGER FDA
PO BOX 7508SILVER SPRINGMD20907750820466955325000PROGRAM ACTIVITIES
NEHI
ONE BROADWAY 15TH FLOORCAMBRIDGEMA2142001062486525000PROGRAM ACTIVITIES
WOMEN IN BIO INC
PO BOX 34043BETHESDAMD208270304582398000PROGRAM ACTIVITIES
PARKINSON'S ACTION NETWORK
1025 VERMONT AVE SUITE 1120WASHINGTONDC200259431726755000SPONSORSHIP501(C)3
AMERICAN CANCER SOCIETY
1599 CLIFTON ROAD NEATLANTAGA303291317884915000SPONSORSHIP501(C)3
COLON CANCER ALLIANCE INC
1025 VERMONT AVE NW SUITE 1066WASHINGTONDC200058609478316000SPONSHORSHIP
SOUTH CAROLINA BIOTECH ASSN
411 UNIVERSITY RIDGE SUITE AGREENVILLENC2960120081395112400SPONSORSHIP501(C)3
CHILDREN'S CAUSE FOR CANCER
750 FIRST ST NE 7TH FLOORWASHINGTONDC200021134856316500SPONSORSHIP
ALS ASSOCIATION
1275 K ST NW SUITE 1050WASHINGTONDC200051332718555000SPONSORSHIP
ALLIANCE FOR AGING RESEARCH
750 17TH ST NW SUITE 1100WASHINGTONDC200065413791745000SPONSORSHIP
FRIENDS OF CANCER RESEARCH
1800 M ST NW SUITE 1050WASHINGTONDC200365219832735000SPONSORSHIP
NATIONAL MULTIPLE SCIEROSIS
1800 M STREET NW S750 SOUTHWASHINGTONDC200365302375855000SPONSORSHIP501(C)3
MICHAEL J FOX FOUNDATION
498 SEVENTH AVENUE 18TH FLOORNEW YORKNY100181340419455000SPONSORSHIP501(C)3
MILKEN INSTITUTE
1250 FOURTH STREET 2ND FLOORSANTA MONICACA9040195424077525000SPONSORSHIP
THE CONGRESSIONAL HUNGER CENTER
400 N CAPITOL ST NW SG100WASHINGTONDC2000152184273810000SPONSORSHIP
WEST VIRGINIA BIOSCIENCE
425 3RD ST SW SUITE 950 SUITE 350HUNTINGTONWV257182713435987300SPONSORSHIP
TEXAS HEALTHCARE
815 BRAZOS ST SUITE 310AUSTINTX787017605010345000SPONSORSHIP
MID-ATLANTIC BIO
1551 EASTLAKE AVE EMCCLEANVA2210255089939710000SPONSORSHIP
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants5TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations13TotalNbrOfOtherOrganizations

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelXFirstClassOrCharterTravel
Travel For CompanionsXTravelForCompanions
Club Dues Or FeesXClubDuesOrFees
Written Policy Re T And E Expenses1WrittenPolicyReTAndEExpenses
Substantiation Required1SubstantiationRequired
Compensation CommitteeXCompensationCommittee
Independent ConsultantXIndependentConsultant
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan1SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement

Form990 Schedule J Part II Form990ScheduleJPartII (20 entries)

TitleTitleBase Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
GREENWOOD JAMES
CEO & PRESIDENT100000005750000002623206934901670581000
JOANNE DUNCAN
CFO & SVP, FINANCE & ADMIN301375015750000251200270740369319000
WHITAKER A SCOTT
COO5702630191475000262320247210812691000
BITTENBENDER FREDERICK
VP, ALLIANCE DEVELOP. & STATE GOVERN324555010000000224820295770386614000
DAMOND JOSEPH
SENIOR VP, INTERNATIONAL AFFAIRS312842024413000254170261970388869000
DILENGE THOMAS
GENERAL COUNSEL3944190132433000262320256420578726000
ENRIGHT CATHLEEN
EVP, FOOD & AGRICULTURE SECTION25171908750000246860217830306938000
EISENBERG ALAN
EXEC VP, EMERGING COMPANIE4114420138148000262320266620602484000
DEL MONTE BRENT
VP, FEDERAL GOVERNMENT REL3657580122809000262320154270530226000
ERICKSON BRENT
EXEC VP, INDUSTRIAL & ENVI336730070000000262320233080456270000
FINAN AMY
VP, CORPORATE DEVELOPMENT280508094185000262320160930417018000
JOSEPH JEFFREY
VP, COMMUNICATIONS2007160978920005000193060318414000
LISAIUS KENNETH
VP, COMMUNICATIONS220376021000000227910204090284576000
LYCETT ROBERTA
VP, CONVENTIONS & CONFEREN274321084098000262320208480405499000
RADCLIFFE SARA
EXEC VP, HEALTH POLICY SEC3506350117731000262320155820510180000
DENNIS SANDRA
DEPUTY GENERAL COUNSEL, HE275971019000000262320177680338971000
SAUER HANSJORG
DEPUTY GENERAL COUNSEL, IN259501032000000242560177680333525000
MCHUGH PETER
COMPLIANCE OFFICER, DEPUTY245417021000000256970177660309880000
FEISEE LILA
VP, INTERNATIONAL AFFAIRS229507035180000241990252750314161000
BASU ABHIJIT
MANAGING DIRECTOR, STATE GOVT RELATI196409046000000216090176930281711000

Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)

Return ReferenceReturnReferenceExplanationExplanation
PART I, LINE 1AJAMES GREENWOOD - FIRST CLASS TRAVEL - $1,281 - TRAVEL FOR COMPANIONS - $3,763 ALAN EISENBERG - FIRST CLASS TRAVEL - $519 - HEALTH/SOCIAL CLUB DUES - $810 CATHLEEN ENRIGHT - FIRST CLASS TRAVEL - $569 JOSEPH DAMOND - FIRST CLASS TRAVEL - $478 THE ABOVE ITEMS WERE NOT INCLUDED IN THE TAXABLE INCOME OF THE INDIVIDUAL.
PART I, LINE 4B. JAMES GREENWOOD 457(F) PLAN NO PAYMENTS IN CURRENT YEAR

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (9 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION A, LINE 2BASED ON RESPONSES TO A SURVEY DISTRIBUTED TO EACH MEMBER OF BIO'S BOARD OF DIRECTORS, TWO DIRECTORS -- VINCENT MILANO AND JOHN MENDLEIN -- DISCLOSED THAT IN 2012 EACH HAD A BUSINESS RELATIONSHIP AS DEFINED BY THE FORM 990 INSTRUCTIONS.
FORM 990, PART VI, SECTION A, LINE 6THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS. ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS. ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER.
FORM 990, PART VI, SECTION A, LINE 7AAT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS, AND THEN SENT TO THE BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS AS WELL. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12CBIO TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIOS COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIOS WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE.
FORM 990, PART VI, SECTION B, LINE 15ATHE PERFORMANCE AND COMPENSATION OF THE PRESIDENT AND CEO OF BIO FOR 2012 WAS REVIEWED AND DETERMINED IN A PROCESS THAT WAS LED BY THE CHAIRMAN OF THE BOARD AND INVOLVED THE FULL EXECUTIVE COMMITTEE OF THE BOARD. THE BIO EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIO BOARD MEMBERS, LEADS AND UNDERTAKES THIS ANNUAL PROCESS. IF NEEDED IN CARRYING OUT THIS PROCESS, THE MEMBERS OF THE EXECUTIVE COMMITTEE CAN BE ASSISTED AND COUNSELED BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDES BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. THE UNDERLYING EXECUTIVE EMPLOYMENT AGREEMENT WAS REVISED AND EXTENDED IN 2011, IN CONSULTATION WITH EXTERNAL INDEPENDENT LEGAL AND COMPENSATION CONSULTANTS AND WITH THE FULL BOARD OF DIRECTORS, AND WITH FINAL APPROVAL BY THE EXECUTIVE COMMITTEE OF THE BOARD. BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2012, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISIONS OF THE EXECUTIVE AGREEMENT. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.
FORM 990, PART XI, LINE 9:CBI REVENUE 41,340. CBI LOBBYING FUND REVENUE 433,424. FOOD & AG INITIATIVES REVENUE 209,301. FOOD & AG INITIATIVES EXPENSES -14,827. FOOD & AG LEGAL FUND 22,762. CBI LOBBYING FUND EXPENSE -469,350. SUSTAINABLE TASK FORCE 9,715.CHANGES IN NET ASSETS OR FUND BALANCES:

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.